← Leaderboards
Aaron W. Aday
Vanderbilt University Medical Center
$1,320,914
Attributed
$1,714,647
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $787.5K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,714,647 · 2
By mechanism
K23$927,180 · 1
R01$787,467 · 1
Top collaborators
- Joshua A Beckman1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Christy M Guth$50,456
Others in their field
Other Emerging Leaders on “Randomized”
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Abraham Aizer Brody · New York University School Of Medicine$23,359,458
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
Research focus
RandomizedBlood PlateletsLimb StructurePeripheral Arterial DiseaseThrombophiliaBlood VesselsEventInflammationLower ExtremityPathway InteractionsThrombinThrombolysisClinical ResearchArterial Fatty StreakAmputationEnvironmentAcuteFutureCessation Of LifeLinkPar-1 ReceptorClinical Trial ImplementationAdhesionsAntithrombin Iii
Grant awards (6)
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease$185,436
K23 · FY2025 · HL · contact PI
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease$185,436
K23 · FY2024 · HL · contact PI
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease$185,436
K23 · FY2023 · HL · contact PI
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease$185,436
K23 · FY2022 · HL · contact PI
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease$185,436
K23 · FY2021 · HL · contact PI
The Impact of Diabetes on Revascularization in BEST-CLI$787,467
R01 · FY2020 · HL · contact PI